Carl Ola Landgren

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Carl Ola Landgren
Dec 20, 2024, 15:28 | Insight
Myeloma Paper of the Day, December 20th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Insights from iStopMM study…
Dec 12, 2024, 12:22 | Insight
Myeloma Paper of the Day, December 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Phase 2 CENTAURUS study…
Jul 25, 2024, 14:07 | Insight
Learn how Carl Ola Landgren is creating a risk profile to personalize myeloma care - HealthTree Foundation
HealthTree Foundation shared on X: "Learn how Dr. C. Ola Landgren and his colleagues at…
Jun 13, 2024, 05:46 | Societies
Carl Ola Landgren: Getting ready with Mohamad Mohty for tomorrow’s opening session at EHA2024
Carl Ola Landgren shared on X: "Getting ready together with Mohamad Mohty for tomorrow’s opening…
Apr 26, 2024, 14:15 | Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 14, 2024, 12:56 | Insight
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared…
Apr 13, 2024, 03:43 | Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
Mar 19, 2024, 21:14 | Blog
Carl Ola Landgren: We had full program in Coral Gables for Multiple Myeloma Awarness Month
Carl Ola Landgren, Chief of Myeloma Division and Translational Clinical Oncology Program at Sylvester Comprehensive…
All: 8 Posts: 1 - 100
Special Coverage